GB1500734A - Phenoxyalkylamines and their preparation - Google Patents
Phenoxyalkylamines and their preparationInfo
- Publication number
- GB1500734A GB1500734A GB4926/75A GB492675A GB1500734A GB 1500734 A GB1500734 A GB 1500734A GB 4926/75 A GB4926/75 A GB 4926/75A GB 492675 A GB492675 A GB 492675A GB 1500734 A GB1500734 A GB 1500734A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- carbon atoms
- aryl
- optionally
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- -1 hydroxy, phenyl Chemical group 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 abstract 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 abstract 1
- 108060003345 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000017910 Adrenergic receptor Human genes 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2019974A IT1059511B (it) | 1974-02-05 | 1974-02-05 | Fenossialchilammine |
| IT1926475A IT1058295B (it) | 1975-01-14 | 1975-01-14 | Fenossialchilammine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1500734A true GB1500734A (en) | 1978-02-08 |
Family
ID=26327112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4926/75A Expired GB1500734A (en) | 1974-02-05 | 1975-02-05 | Phenoxyalkylamines and their preparation |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3988475A (en:Method) |
| JP (1) | JPS5412458B2 (en:Method) |
| CA (1) | CA1052791A (en:Method) |
| DE (1) | DE2504790C3 (en:Method) |
| ES (1) | ES434421A1 (en:Method) |
| FR (1) | FR2259594B1 (en:Method) |
| GB (1) | GB1500734A (en:Method) |
| NL (1) | NL162062C (en:Method) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1493848A (en) * | 1975-07-24 | 1977-11-30 | Beecham Group Ltd | Aryltetralins |
| US4155907A (en) * | 1976-08-16 | 1979-05-22 | The Dow Chemical Company | Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines |
| EP0062596B1 (fr) * | 1981-04-06 | 1985-07-03 | Cortial S.A. | Nouveaux dérivés d'aminoéthoxy-4 isopropyl-5 méthyl-2 phénol, leur méthode de préparation et leur emploi en tant que médicaments |
| IT1240598B (it) * | 1990-03-13 | 1993-12-17 | Mini Ricerca Scient Tecnolog | Derivati amminici ad azione antifungina |
| US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| US6432986B2 (en) | 1997-07-21 | 2002-08-13 | Bruce H. Levin | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| SE9704770D0 (sv) * | 1997-12-19 | 1997-12-19 | Astra Ab | New use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH380746A (de) * | 1958-11-06 | 1964-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer sekundärer Amine |
| JPS4427369Y1 (en:Method) * | 1966-12-01 | 1969-11-15 | ||
| US3632779A (en) * | 1969-03-06 | 1972-01-04 | Dow Chemical Co | Method using (dialkylaminoethoxy) halomethoxyanilines for alleviating cardiac arrhythmias |
-
1975
- 1975-01-31 US US05/545,946 patent/US3988475A/en not_active Expired - Lifetime
- 1975-02-04 FR FR7503404A patent/FR2259594B1/fr not_active Expired
- 1975-02-04 ES ES434421A patent/ES434421A1/es not_active Expired
- 1975-02-05 JP JP1522575A patent/JPS5412458B2/ja not_active Expired
- 1975-02-05 DE DE2504790A patent/DE2504790C3/de not_active Expired
- 1975-02-05 NL NL7501371.A patent/NL162062C/xx not_active IP Right Cessation
- 1975-02-05 GB GB4926/75A patent/GB1500734A/en not_active Expired
- 1975-02-05 CA CA219,402A patent/CA1052791A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2504790A1 (de) | 1975-08-07 |
| NL162062C (nl) | 1980-04-15 |
| JPS50112326A (en:Method) | 1975-09-03 |
| FR2259594B1 (en:Method) | 1978-07-21 |
| DE2504790B2 (de) | 1977-12-29 |
| FR2259594A1 (en:Method) | 1975-08-29 |
| CA1052791A (en) | 1979-04-17 |
| DE2504790C3 (de) | 1978-08-31 |
| NL7501371A (nl) | 1975-08-07 |
| US3988475A (en) | 1976-10-26 |
| JPS5412458B2 (en:Method) | 1979-05-23 |
| ES434421A1 (es) | 1977-03-16 |
| AU7788875A (en) | 1976-08-12 |
| NL162062B (nl) | 1979-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1456253A (en) | Piperazine derivatives | |
| GB1345880A (en) | Pyridazine derivatives | |
| IE41539L (en) | Chroman derivatives. | |
| GB1466646A (en) | Substituted benzamides | |
| GB1147379A (en) | 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts | |
| GB1488692A (en) | Pyrazolo(3,4,6)quinolines | |
| GB1296561A (en:Method) | ||
| GB1500734A (en) | Phenoxyalkylamines and their preparation | |
| GB1264485A (en:Method) | ||
| GB1456627A (en) | Pyridobenzodiazepinones | |
| GB1489711A (en) | 1-phenoxyphenyl-piperazine derivatives process for their preparation and pharmaceutical compositions containing the | |
| GB1460071A (en) | Tetrahydronaphthyloxy-amines and related compounds | |
| GB1016071A (en) | New guanidine derivatives and process for preparing the same | |
| GB1342321A (en) | Nitrofuran derivatives | |
| GB1505899A (en) | 3,4-dihydrocarbostyril derivatives | |
| GB1212454A (en) | N,n'-substituted formamidines | |
| GB1144516A (en) | Novel oximes and a process for the manufacture and conversion thereof | |
| GB1367305A (en) | Benzodiazocine derivatives | |
| GB1433078A (en) | Substituted phenethylamines | |
| GB1455356A (en) | Imidazotriazines | |
| GB1430551A (en) | Piperazine derivatives | |
| GB1140853A (en) | New hydroxy biguanides and processes for preparing same | |
| GB1180249A (en) | Quinoxaline Compounds, their preparation and Compositions containing them | |
| GB1382602A (en) | Benzodioxan compounds and process for preparing the same | |
| GB1280887A (en) | New isothiocyano-diphenylamines their production and compositions containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |